The impact of new tuberculosis diagnostics on transmission: Why context matters;Impact des nouveaux diagnostics de la tuberculose sur sa transmission: Pourquoi le contexte est important

Bulletin of the World Health Organization

Volumn 90, Issue 10, 2012, Pages

  Lin, Hsien Ho ^a   Dowdy, David ^b   Dye, Christopher ^c   Murray, Megan ^d   Cohen, Ted ^e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFIDENCE INTERVAL; DISEASE INCIDENCE; DISEASE TRANSMISSION; EPIDEMIOLOGY; HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; TUBERCULOSIS;

ARTICLE; DEATH; DELAYED DIAGNOSIS; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; EPIDEMIC; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG TUBERCULOSIS; MICROSCOPY; SENSITIVITY ANALYSIS; SPUTUM SMEAR; SYMPTOMATOLOGY; TANZANIA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

BACTERIAL TYPING TECHNIQUES; BAYES THEOREM; HIV INFECTIONS; HUMANS; INCIDENCE; MICROSCOPY; MODELS, BIOLOGICAL; SENSITIVITY AND SPECIFICITY; SPUTUM; TANZANIA; TUBERCULOSIS;

TANZANIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84867133991     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.11.101436     Document Type: Article

References (27)

1. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 2009;30:701-16. doi:10.1016/j.ccm.2009.08.016 PMID:19925962
2. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010;16:271-84. PMID:20224410
3. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD etal. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010;375:1920-37. doi:10.1016/S0140- 6736(10)60359-5 PMID:20488517
4. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F etal. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-15.doi:10.1056/NEJMoa0907847 PMID:20825313
5. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R etal. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011;377:1495-505. doi:10.1016/ S0140-6736(11)60438-8 PMID:21507477
6. Boehme CC, Nabeta P, Henostroza G, Raqib R, Rahim Z, Gerhardt M etal. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007;45:1936-40. doi:10.1128/JCM.02352-06 PMID:17392443
7. Cuevas LE, Al-Sonboli N, Lawson L, Yassin MA, Arbide I, Al-Aghbari N etal. LED fluorescence microscopy for the diagnosis of pulmonary tuberculosis: a multi-country cross-sectional evaluation. PLoS Med 2011;8:e1001057. doi:10.1371/journal.pmed.1001057 PMID:21765809
8. Ling DI, Zwerling AA, Pai M. Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy. Expert Rev Respir Med 2008;2:583-8.doi:10.1586/17476348.2.5.583 PMID:20477293
9. Dowdy DW, Cattamanchi A, Steingart KR, Pai M. Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med 2011;8:e1001063.doi:10.1371/journal.pmed.1001063 PMID:21814496
10. Squire SB, Belaye AK, Kashoti A, Salaniponi FM, Mundy CJ, Theobald S etal. 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 2005;9:25-31. PMID:15675546
11. Cohen T, Lipsitch M, Walensky RP, Murray M. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc Natl Acad Sci USA 2006;103:7042-7. doi:10.1073/pnas.0600349103 PMID:16632605
12. Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 1998;352:1886-91. doi:10.1016/S0140- 6736(98)03199-7 PMID:9863786
13. Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr, Dye C et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA 2009;106:13980-5. doi:10.1073/pnas.0901720106 PMID:19666590
14. Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci USA 2008;105:11293-8. doi:10.1073/pnas.0800965105 PMID:18695217
15. Dowdy DW, Chaisson RE, Moulton LH, Dorman SE. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS 2006;20:751-62. doi:10.1097/01. aids.0000216376.07185.cc PMID:16514306
16. Murray CJ, Salomon JA. Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA 1998;95:13881-6. doi:10.1073/ pnas.95.23.13881 PMID:9811895
17. Alkema L, Raftery AE, Brown T. Bayesian melding for estimating uncertainty in national HIV prevalence estimates. Sex Transm Infect 2008;84(Suppl 1):i11-6.doi:10.1136/sti.2008.029991 PMID:18647860
18. Joint United Nations Programme on HIV/AIDS [Internet]. Epidemiological Fact Sheet: United Republic of Tanzania. Geneva: UNAIDS; 2011. Available from: http://www.unaids.org/en/regionscountries/countries/ unitedrepublicoftanzania/ [accessed 2 July 2012].
19. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. Geneva: World Health Organization; 2009.
20. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL etal. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353:444-9. doi:10.1016/ S0140-6736(98)03406-0 PMID:9989714
21. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997;119:183-201.doi:10.1017/S0950268897007917 PMID:9363017
22. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995;274:143-8. doi:10.1001/jama.1995.03530020061033 PMID:7596002
23. Rieder HL. Epidemiologic basis of tuberculosis control. Paris: International Union Against Tuberculosis and Lung Disease; 1999.
24. Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis 2012;54:784-91. doi:10.1093/ cid/cir951 PMID:22267721
25. FitzGerald JM, Grzybowski S, Allen EA. The impact of human immunodeficiency virus infection on tuberculosis and its control. Chest 1991;100:191-200.doi:10.1378/chest.100.1.191 PMID:2060342
26. Hughes G, Currie C, Corbett EL. Modeling tuberculosis in areas of high HIV prevalence. In: Simulation Conference 2006, proceedings for the winter; Monterey, 3-6 December2006. pp. 459-65.
27. Sanchez MA, Blower SM. Uncertainty and sensitivity analysis of the basic reproductive rate. Tuberculosis as an example. Am J Epidemiol 1997;145:1127-37.doi:10.1093/oxfordjournals.aje.a009076 PMID:9199543